As per the agreement, Quest and Hemispherx will equally share the clinical trial’s expenses.
Hemispherx will offer technical expertise and relevant data to support the regulatory process necessary for organizing the clinical trial.
Hemispherx will also store and maintain clinical supply inventory of Oregovomab at its manufacturing facility in New Brunswick.